Assertio Therapeutics has acquired 1 company. It has also divested 1 asset.
Assertio Therapeutics’ largest acquisition to date was in 2013, when it acquired Nautilus Neurosciences - CAMBIA® for $49M. Assertio Therapeutics has acquired in 1 US state. The Company’s most targeted sectors include medical products (100%).
Join Mergr and gain access to Assertio Therapeutics’ M&A summary, the M&A summaries of companies just like it, as well as recent M&A activity in the life science sector.
100 South Saunders Road Suite 300,
Newark,
California 60045
United States,
(224) 419-7106
www.assertiotx.comSector
Assertio Therapeutics, Inc. is a pharmaceutical company focused on products to treat pain and other central nervous system (CNS) conditions. Assertio Therapeutics was founded in 1995 and is based in Lake Forest, Illinois.
| Year | ≤ '14 | '15 | '16 | '17 | '18 | '19 | T | |
|---|---|---|---|---|---|---|---|---|
| Buy (0.0/yr) | # | 1 | - | - | - | - | - | 1 |
| vol | $49M | $49M | ||||||
| Sell (0.2/yr) | # | - | 1 | - | - | - | - | 1 |
| 2 | ||||||||
| Financial | Deals |
|---|---|
| Join to Access. | |
| Legal | Deals |
|---|---|
| Join to Access. | |
| Buy | # | TOTAL |
|---|---|---|
| > $1B | Sign-up to View | |
| $100M to $1B | Sign-up to View | |
| < $100M | Sign-up to View | |
| TOTAL | Sign-up to View | |
| Largest |
Nautilus Neurosciences - CAMBIA® (Diclofenac Potassium for Oral Solution) $49M (2013-12-17) |
|
| Sell | # | Total |
|---|---|---|
| > $1B | Sign-up to View | |
| $100M to $1B | Sign-up to View | |
| < $100M | Sign-up to View | |
| Total | Sign-up to View | |
When analyzing the life science sector as a whole, according to Mergr, in the last 3 years, there are 387 life science companies that have made at least 1 acquisition, 17 have acquired at least 5 companies, and 2 have acquired more than 10 companies.
The most prolific strategic life science acquirer over the past 3 years is Eurofins Scientific SA, with 21 acquisitions. The most prolific private equity acquirer in the life science sector over the past 3 years is Avista Capital Partners with 6 platform acquisitions.
We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.
Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.
Try us for 1 week free today!
No obligation. Cancel anytime.
